Citation

Gooch CL, Pracht E, Borenstein AR. Ann. Neurol. 2017; 81(4): 479-484.

Affiliation

Department of Epidemiology and Biostatistics, University of South Florida College of Public Health.

Copyright

(Copyright © 2017, John Wiley and Sons)

DOI

10.1002/ana.24897

PMID

28198092

Abstract

The United States carries a substantial fiscal burden resulting from the nearly 100 million Americans with neurological disease. The combined annual costs of Alzheimer's and other dementias, low back pain, stroke, traumatic brain injury, migraine, epilepsy, multiple sclerosis, spinal cord injury and Parkinson's disease totals nearly 800 billion dollars and is rapidly rising due to the aging of the U.S. POPULATION: We provide a summary overview of the substantial current and future economic impact of neurological disease, and provide an action plan for reducing this burden through neurological research and enhanced clinical management of neurological disorders in the United States. This article is protected by copyright. All rights reserved.

© 2017 American Neurological Association.

Language: en